🧬
Gen Terapisi Sektörü Hisseleri
Gen Terapisi Sektörü altında 56 Hisse Senedi
Gen Terapisi sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
56
Toplam Hisse
$25.2B
Toplam Piyasa Değeri
Gen Terapisi Sektörü Hisseleri
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $3.72B | $125.96 | 0.28% | |
| SRPT | Sarepta Therapeutics, Inc. | $3.52B | $37.60 | 2.62% | |
| ACLX | Arcellx, Inc. | $3.21B | $62.06 | 2.54% | |
| LEGN | Legend Biotech Corporation | $2.61B | $28.95 | 0.07% | |
| BEAM | Beam Therapeutics Inc. | $1.82B | $15.83 | 3.00% | |
| DYN | Dyne Therapeutics, Inc. | $1.34B | $11.96 | 2.29% | |
| RCKT | Rocket Pharmaceuticals, Inc. | $649.66M | $2.51 | 4.20% | |
| IOVA | Iovance Biotherapeutics, Inc. | $564.35M | $1.75 | 4.37% | |
| REPL | Replimune Group, Inc. | $541.80M | $8.98 | 4.16% | |
| STOK | Stoke Therapeutics, Inc. | $481.00M | $9.54 | 1.95% | |
| TSHA | Taysha Gene Therapies, Inc. | $472.65M | $2.71 | 1.45% | |
| RGNX | REGENXBIO Inc. | $419.34M | $8.85 | 1.34% | |
| SANA | Sana Biotechnology, Inc. | $395.85M | $2.17 | 4.41% | |
| MGTX | MeiraGTx Holdings plc | $369.44M | $5.12 | 4.48% | |
| BNTC | Benitec Biopharma Inc. | $336.70M | $15.36 | 1.48% | |
| ARCT | Arcturus Therapeutics Holdings Inc. | $321.65M | $12.53 | 1.57% | |
| FULC | Fulcrum Therapeutics, Inc. | $305.52M | $6.88 | 2.76% | |
| TRDA | Entrada Therapeutics, Inc. | $304.77M | $7.60 | 3.80% | |
| ABEO | Abeona Therapeutics Inc. | $274.74M | $6.24 | 1.30% | |
| TSVT | 2seventy bio, Inc. | $266.15M | $5.00 | 0.00% | |
| RNAC | Cartesian Therapeutics, Inc. | $259.41M | $9.56 | 4.40% | |
| ALLO | Allogene Therapeutics, Inc. | $247.14M | $1.17 | 0.85% | |
| NGNE | Neurogene Inc. | $213.93M | $17.01 | 9.23% | |
| SLDB | Solid Biosciences Inc. | $195.69M | $3.21 | 2.73% | |
| DSGN | Design Therapeutics, Inc. | $195.57M | $3.73 | 6.98% | |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $181.23M | $4.25 | 0.71% | |
| PRME | Prime Medicine, Inc. | $161.49M | $1.18 | 6.35% | |
| FDMT | 4D Molecular Therapeutics, Inc. | $145.69M | $3.62 | 2.43% | |
| KRRO | Korro Bio, Inc. | $139.64M | $11.42 | 2.64% | |
| NKTX | Nkarta, Inc. | $134.82M | $1.74 | 3.87% | |
| LYEL | Lyell Immunopharma, Inc. | $120.82M | $0.44 | 8.74% | |
| EDIT | Editas Medicine, Inc. | $118.45M | $1.72 | 6.01% | |
| LRMR | Larimar Therapeutics, Inc. | $113.33M | $2.25 | 2.17% | |
| FATE | Fate Therapeutics, Inc. | $112.85M | $1.21 | 8.33% | |
| SGMO | Sangamo Therapeutics, Inc. | $105.51M | $0.47 | 1.59% | |
| KYTX | Kyverna Therapeutics, Inc. | $90.54M | $2.55 | 3.04% | |
| TIL | Instil Bio, Inc. | $87.76M | $26.95 | 11.20% | |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $85.48M | $2.72 | 5.23% | |
| CABA | Cabaletta Bio, Inc. | $66.98M | $1.87 | 2.09% | |
| TNYA | Tenaya Therapeutics, Inc. | $61.85M | $0.46 | 3.51% | |
| ACET | Adicet Bio, Inc. | $55.25M | $0.72 | 0.24% | |
| DTIL | Precision BioSciences, Inc. | $54.33M | $4.83 | 1.83% | |
| ARTV | Artiva Biotherapeutics, Inc. | $49.94M | $1.93 | 5.85% | |
| ALVR | AlloVir, Inc. | $49.48M | $9.81 | 4.14% | |
| ADVM | Adverum Biotechnologies, Inc. | $46.27M | $2.22 | 1.77% | |
| PEPG | PepGen Inc. | $44.99M | $1.46 | 12.57% | |
| ATRA | Atara Biotherapeutics, Inc. | $39.82M | $7.80 | 0.00% | |
| BLUE | bluebird bio, Inc. | $32.41M | $4.97 | 0.00% | |
| INKT | MiNK Therapeutics, Inc. | $27.81M | $7.03 | 1.01% | |
| GBIO | Generation Bio Co. | $26.20M | $0.38 | 2.58% | |
| PASG | Passage Bio, Inc. | $16.97M | $0.44 | 3.41% | |
| ERNA | Eterna Therapeutics Inc. | $13.71M | $0.22 | 4.80% | |
| PHIO | Phio Pharmaceuticals Corp. | $8.86M | $2.00 | 1.96% | |
| CARM | Carisma Therapeutics, Inc. | $7.76M | $0.19 | 4.56% | |
| GNPX | Genprex, Inc. | $5.63M | $0.33 | 0.24% | |
| TCRT | Alaunos Therapeutics, Inc. | $4.74M | $2.46 | 4.65% |